Sensitivity of the Montreal Cognitive Assessment in screening for cognitive impairment in patients with newly diagnosed high-grade glioma.

Fiche publication

Date publication

mai 2020

Journal

Journal of neuro-oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr NOEL Georges

Tous les auteurs :
Ribeiro M, Durand T, Roussel M, Feuvret L, Jacob J, Psimaras D, Noel G, Keller A, Bompaire F, Hoang-Xuan K, Bernier MO, Godefroy O, Ricard D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32415644

Résumé

Cognitive impairment is frequent in patients with high-grade glioma and requires cognitive follow-up. Cognitive screening tools such as the Montreal Cognitive Assessment (MoCA) have been used to assess cognition in these patients. Here we assessed the sensitivity of the MoCA in screening for cognitive impairment in a cohort of 156 patients with newly-diagnosed high-grade glioma, after surgery and before radiochemotherapy.